retatrutide dosing clinical trial Guide: 1-12 mg Weekly Triple Agonist (2026) retatrutide dose study trial doses

Retatrutide microdosing has become one of the most debated topics in the peptide community

Additional research reviewed by Erica M

For women who have felt failed by extreme diets or aggressive interventions, this approach represents a meaningful shift

For a 250-pound person, that would mean losing around 72 pounds in about 16 months

A recent review in Nutrients explores what we currently know about how GLP-1 RAs interact with gut microbesand the broader implications for human health

Unfortunately, with individual differences and a lack of research, its difficult to say what determines the interaction between GLP-1s and psychedelics